Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacillus subtilis is a Gram-positive, rod-shaped, spore-forming bacterium ubiquitously found in soil, water, plants, and the GI tract of animals and humans[1][3][5][7]. It is highly resilient to environmental stresses through the formation of tough endospores, enabling survival in extreme conditions[1][7]. B. subtilis is one of the most studied model organisms among Gram-positive bacteria and is noted for its rapid growth, ability to differentiate (including into spores and biofilms), and genetic tractability[5][6][7]. Its genome has been fully sequenced, and it serves as a key system for studying cellular processes such as replication, transcription, and protein secretion[5][6]. B. subtilis is of significant industrial and biotechnological importance, being used in enzyme production, as a source of antibiotics and antimicrobial peptides (e.g., subtilin, subtilosin A), probiotics, and biocontrol agents in agriculture[2][3][4][8]. Despite occasional rare infections, it is largely considered non-pathogenic to humans and is commonly used in food and health products[7]. Note: Bacillus subtilis is not a molecular drug target such as a specific enzyme, receptor, or transporter. Rather, it is a whole bacterial species and model organism. Therefore, it would be flagged as an incorrect entry as a *molecular target* for structured drug discovery databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacillus subtilis (B. subtilis).